State-of-the-Art Care for Patients With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

Download All
Learn how the experts are leveraging the most recent data and incorporating novel targeted therapy to manage pediatric patients with neurofibromatosis type 1 plexiform neurofibromas with these downloadable slides, podcast, and on-demand webcast capturing a live CCO webinar.
person default
Scott Plotkin, MD, PhD
person default
Brian D. Weiss, MD

Downloadable Slides and Clinical ExpressPoints

Download these slides from a live Webinar for the latest evidence on targeted therapy focused on MEK inhibitors for the management of plexiform neurofibromas in patients with NF1.

person default Brian D. Weiss, MD Released: June 22, 2021

Download these slides from a live Webinar for an overview of the pathophysiology of NF1 and the latest evidence on the management of patients with NF1.

person default Scott Plotkin, MD, PhD Released: June 22, 2021

Download these summary slides from a live Webinar for expert insight on the management of patients with NF1 and plexiform neurofibromas including the latest evidence on MEK inhibitors for these patients.

person default Scott Plotkin, MD, PhD person default Brian D. Weiss, MD Released: June 23, 2021

On Demand Webcast

In this interactive on-demand webcast, expert faculty will discuss the pathophysiology and management of neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas.

person default Scott Plotkin, MD, PhD person default Brian D. Weiss, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit ABIM MOC: maximum of 1.0 Medical Knowledge MOC point(s) Released: July 13, 2021 Expired: July 12, 2022

Audio Podcast (With Podcast Pearls Summary Transcript)

In this podcast episode, listen to Scott R. Plotkin, MD, PhD, and Brian D. Weiss, MD, as they answer questions on managing NF1 and using MEK inhibitors for NF1-associated plexiform neurofibromas.

person default Scott Plotkin, MD, PhD person default Brian D. Weiss, MD Released: July 12, 2021

Download this short summary of key takeaways from a podcast on managing patients with NF1 including the use of MEK inhibitors for plexiform neurofibromas.

person default Scott Plotkin, MD, PhD person default Brian D. Weiss, MD Released: July 12, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue